Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Waters

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Vascular Health and Risk Management|June 18, 2015
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in SingaporeSajita Setia, Selwyn Sze-Wang Fung, David D Waters
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23219296David D Waters, S Matthijs Boekholdt, Terje R Pedersen
American Heart Journal|March 25, 2014
Cardiovascular drugs that increase the risk of new-onset diabetesKwok Leung Ong, Philip J Barter, David D Waters
The Canadian Journal of Cardiology|September 12, 2009
A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints SymposiumTherese Heinonen, David D Waters, Peter Libby, et al.
Journal of Pharmacy Practice|October 5, 2017
RE: Praluent (Alirocumab)-Induced Renal InjuryRobert S Rosenson, Dominique Larrey, David D Waters, et al.
The Canadian Journal of Cardiology|July 12, 2019
Improving Statin Noncompliance: If You Build It, Will They Come?Robert T Sparrow, Laura Ferreira-Legere, Jacob A Udell, et al.
The American Journal of Cardiology|September 12, 2016
Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)Payal Kohli, Joshua W Knowles, Ashish Sarraju, et al.
Circulation. Cardiovascular Quality and Outcomes|December 21, 2018
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes MellitusSripal Bangalore, Rana Fayyad, David A DeMicco, et al.
The American Journal of Cardiology|January 16, 2007
Statin therapy in acute coronary syndromeVincent E Friedewald, Ruth McPherson, Robert Roberts, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individualsEric Secemsky, David Lange, David D Waters, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Vascular Health and Risk Management|June 18, 2015
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in SingaporeSajita Setia, Selwyn Sze-Wang Fung, David D Waters
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23219296David D Waters, S Matthijs Boekholdt, Terje R Pedersen
American Heart Journal|March 25, 2014
Cardiovascular drugs that increase the risk of new-onset diabetesKwok Leung Ong, Philip J Barter, David D Waters
The Canadian Journal of Cardiology|September 12, 2009
A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints SymposiumTherese Heinonen, David D Waters, Peter Libby, et al.
Journal of Pharmacy Practice|October 5, 2017
RE: Praluent (Alirocumab)-Induced Renal InjuryRobert S Rosenson, Dominique Larrey, David D Waters, et al.
The Canadian Journal of Cardiology|July 12, 2019
Improving Statin Noncompliance: If You Build It, Will They Come?Robert T Sparrow, Laura Ferreira-Legere, Jacob A Udell, et al.
The American Journal of Cardiology|September 12, 2016
Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)Payal Kohli, Joshua W Knowles, Ashish Sarraju, et al.
Circulation. Cardiovascular Quality and Outcomes|December 21, 2018
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes MellitusSripal Bangalore, Rana Fayyad, David A DeMicco, et al.
The American Journal of Cardiology|January 16, 2007
Statin therapy in acute coronary syndromeVincent E Friedewald, Ruth McPherson, Robert Roberts, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individualsEric Secemsky, David Lange, David D Waters, et al.
Pageof 16